Clofurac
- Level
- Commodity
- Parent
- 51382200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51382201This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H15ClO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0V7WAB3NV4, chemically known as 5-chloro-6-cyclohexyl-2,3-dihydrobenzofuran-2-one but generally known as clofurac, which bears US NIH Compound Identifier 68806. European Medicines Agency schedules Clofurac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06713MIG. The term CLOFURAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). CLOFURAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CLOFURAC remains the US FDA Preferred Term for this commodity. Clofurac bears US NLM identifiers UMLS ID C2699370 and NCI Concept Code C77347. SMILES: CLC1C(C2CCCCC2)CC2OC(=O)CC2C1.
Same parent
Under 51382200 · 2Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.